000 | 01321 a2200373 4500 | ||
---|---|---|---|
005 | 20250515023452.0 | ||
264 | 0 | _c20060714 | |
008 | 200607s 0 0 eng d | ||
022 | _a1538-7933 | ||
024 | 7 |
_a10.1111/j.1538-7836.2006.01875.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWarkentin, T E | |
245 | 0 | 0 |
_aShould vitamin K be administered when HIT is diagnosed after administration of coumarin? _h[electronic resource] |
260 |
_bJournal of thrombosis and haemostasis : JTH _cApr 2006 |
||
300 |
_a894-6 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter | ||
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
650 | 0 | 4 | _aCardiac Surgical Procedures |
650 | 0 | 4 |
_aCoumarins _xtherapeutic use |
650 | 0 | 4 | _aExtremities |
650 | 0 | 4 |
_aGangrene _xpathology |
650 | 0 | 4 |
_aHeparin _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInternational Normalized Ratio |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNecrosis |
650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
650 | 0 | 4 |
_aVitamin K _xtherapeutic use |
650 | 0 | 4 | _aWarfarin |
773 | 0 |
_tJournal of thrombosis and haemostasis : JTH _gvol. 4 _gno. 4 _gp. 894-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1538-7836.2006.01875.x _zAvailable from publisher's website |
999 |
_c16238368 _d16238368 |